Article info

PDF
Long-term safety and efficacy of ziv-aflibercept in retinal diseases

Authors

  1. Correspondence to Dr Jay Chhablani, Smt. Kanuri Santhamma Centre for Vitreoretinal Diseases, LV Prasad Eye Institute, Banjara Hills, Hyderabad, AP 500034, India; jay.chhablani{at}gmail.com
View Full Text

Citation

Mansour AM, Ashraf M, Dedhia CJ, et al
Long-term safety and efficacy of ziv-aflibercept in retinal diseases

Publication history

  • Received 11 October 2016
  • Revised 10 January 2017
  • Accepted 11 February 2017
  • Published in print 1 October 2017.
  • Published online 26 September 2017.
  • Published first 7 March 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.